Merck to Present at Morgan Stanley Global Healthcare Conference

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Peter N. Kellogg, Merck's chief financial officer, is scheduled to present at the Morgan Stanley Global Healthcare Conference in New York on Sept. 13 at 8:35 a.m. EDT. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation at http://www.merck.com/investors/events-and-presentations/home.html. An archive of the presentation will be available at the same location.

About Merck

Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com.



CONTACT:

Merck
Media:
Steven Campanini, 908-423-4291
or
Investors:
Carol Ferguson, 908-423-4465

KEYWORDS:   United States  North America  New Jersey  New York

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Other Health

MEDIA:

Logo
 Logo

Suggested Articles

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

Gilead Sciences is the latest drugmaker to settle Justice Department claims that its charity contributions were actually kickbacks.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.